Particularly, proliferative targets of MDM2 include the stimulation of E2F1 transcriptional activity [19], increased E2F1 protein stability [20], disruption of the Rb-E2F1 complex and inhibition of tumor suppressive functions of Rb [21–23]. This evidence concerns the gene E2F1 and neoplasm.